Literature DB >> 8150964

Isolation of hepatitis C virus RNA from serum for reverse transcription-PCR.

F S Nolte1, C Thurmond, P S Mitchell.   

Abstract

Standard multistep extraction and isolation of RNA for hepatitis C virus (HCV) reverse transcription (RT)-PCR are impractical for routine use in clinical laboratories. We compared three simple commercially available methods for RNA isolation (RNAzol B, TRISOLV, and ULTRASPEC; Biotecx Laboratories, Houston, Tex.) and a total nucleic acid isolation method (IsoQuick; MicroProbe Corp., Garden Grove, Calif.) for the recovery of HCV RNA from sera obtained from 12 viremic patients for RT-PCR. RNAzol B, TRISOLV, ULTRASPEC, and IsoQuick extraction methods detected 87.5, 79.2, 33.3, and 58.3% of the paired positive samples, respectively. The method used for isolation of RNA is an important concern when optimizing HCV RT-PCR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150964      PMCID: PMC263065          DOI: 10.1128/jcm.32.2.519-520.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.

Authors:  P Farci; H J Alter; D Wong; R H Miller; J W Shih; B Jett; R H Purcell
Journal:  N Engl J Med       Date:  1991-07-11       Impact factor: 91.245

2.  Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma.

Authors:  T A Cha; J Kolberg; B Irvine; M Stempien; E Beall; M Yano; Q L Choo; M Houghton; G Kuo; J H Han
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

5.  Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients.

Authors:  P Bouffard; P H Hayashi; R Acevedo; N Levy; J B Zeldis
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

6.  Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory.

Authors:  D Gretch; W Lee; L Corey
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

7.  Impact of specimen handling and storage on detection of hepatitis C virus RNA.

Authors:  M P Busch; J C Wilber; P Johnson; L Tobler; C S Evans
Journal:  Transfusion       Date:  1992-06       Impact factor: 3.157

8.  Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay.

Authors:  K K Young; R M Resnick; T W Myers
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

9.  Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.

Authors:  J A Garson; R S Tedder; M Briggs; P Tuke; J A Glazebrook; A Trute; D Parker; J A Barbara; M Contreras; S Aloysius
Journal:  Lancet       Date:  1990-06-16       Impact factor: 79.321

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  8 in total

1.  Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.

Authors:  J T Abrams; E C Vonderheid; S Kolbe; D M Appelt; E J Arking; B J Balin
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA.

Authors:  H J Lin; M Haywood; F B Hollinger
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

3.  Long PCR and its application to hepatitis viruses: amplification of hepatitis A, hepatitis B, and hepatitis C virus genomes.

Authors:  R Tellier; J Bukh; S U Emerson; R H Miller; R H Purcell
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

Review 4.  Respiratory syncytial virus infection in the elderly.

Authors:  G Mlinaric-Galinovic; A R Falsey; E E Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

5.  Cooperative oligonucleotides mediating direct capture of hepatitis C virus RNA from serum.

Authors:  D O'Meara; Z Yun; A Sönnerborg; J Lundeberg
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

6.  Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA.

Authors:  F S Nolte; C Thurmond; M W Fried
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

7.  Enhanced amplification of hepatitis C virus (HCV) cDNA by PCR: detection of HCV RNA in archival sera.

Authors:  A M Beardsley; E J Gowans; C J Burrell; B P Marmion
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

8.  Extraction of HCV-RNA from Plasma Samples: Development towards Semiautomation.

Authors:  Imran Amin; Tania Jabbar; Fawad Niazi; Muhammad Saeed Akhtar
Journal:  Int J Anal Chem       Date:  2015-03-19       Impact factor: 1.885

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.